qaMqaoARcPSD|301h380h4
lO
TESTBANK - h
LilleysPharmacologyfor CanadianH
h
RePractice,4th Edition(Sealock),Ch
58|All Chapters
h h
,TABLEOFCONTENTS
,Chapter 01: Nursing Practice in CanadaandDrug Therapy
qa qa qa qa qa aq qa
Sealock: Lilley’s Pharmacologyfor Canadian Health Care Practice, 4th Edition
qa qa qa qa qa qa qa qa
MULTIPLE CHOICE qa
1. Which is aj udgement about aparticularpatient’spotential need or problem?
h qa qa h h qa qa qa hqa h
a. A goal h
b. An assessment h
c. Subjective data qa
d. A nursing diagnosis h h
ANSWER: D hq a
Nursing diagnosis isthe phase of the nursing process during which a clinical judgement is made about how
h hqa qa hqa qa h hqa h h h hqa qa hqa
onditions and life processesor vulnerability forthatresponse.
qa qa qa qa qa
DIF: Cognitive Level:Knowledge qa
2. The patient is to receiveoral furosemide (Lasix)e veryday; however, because the patient is unable to swallow
hqa qa qa qa qa qa hqa qa qa hqa qa qa qa
ation orally, asordered. The nurse needs to contact thephysician. What type of problem is this?
h qa qa qa qa qa h hqa qa hqa h h hqa qa
a. A “right time”problem h qa
b. A “right dose”problem h h
c. A “right route”problemh h
d. A “right medication”problem
h qa
ANSWER: C q a
This is a “right route” problem: the nurse cannot assume the routeand must clarify the route with the prescrib
qa h hq a h qa qa qa h qa qa qa h qa qa qa h
roblembecause the ordered frequency has not changed. This is not a “right dose”problembecause thedose is
h qa hqa qa qa h qa qa qa h qa h h qa qa
wallow.This is not a “right medication”problembecauset he medication ordered will not change, just ther
qa hqa h qa hqa qa h qa hqa h qa qa qa qa hqa qa
DIF: CognitiveLevel: Application qa h
3. The nurse has been monitoringthe patient’sprogresson his newdrug regimen sincethe first dosea nd has been hqa qa hqa qa h h qa qa h qa hqa
ible adverseeffects. What nursing process phase is the nursepractising?
qa qa qa qa h qa qa hqa
a. Planning
b. Evaluation
c. Implementation
d. Nursing diagnosis h
ANSWER: B q a
Monitoring thepatient’sprogress ispart of thee valuation phase. Planning, implementation, a nd nursing diagn
h qa qa qa qa h h qa h qa qa qa hqa h
xample.
DIF: CognitiveLevel: Application qa h
4. Thenurse is caring fora patient who hasbeen newlydiagnosed with type 1 diabetes mellitus. Which statemen
qa h hqa h qa hqa qa h h qa qa qa h
mecriterion for this patient?
qa hqa h
a. Thepatient willfollow instructions. qa h qa
b. Thepatient will notexperience complications. qa hq a qa
c. Thepatientadherestothe new insulin treatment regimen. qa qa qa qa qa h qa
d. Thepatientdemonstratessafe insulin self-administrationtechnique. qa qa h
ANSWER: D hq a
Having the patient demonstrate safe insulin self-
h qa h qa qa h
administration technique is a specific and measurable outcome criterion. Followinginstructions and avoidin
h qa qa h qa hqa qa qa qa h qa qa
iccriteria. Adherencetothe newi nsulin treatment regimen is not objective andwouldbedifficultto measure
qa qa qa qa qa qa h qa hqa h qa h qa qa qa qa qa
DIF: CognitiveLevel: Application qa h
, Copyright © 2021, Elsevier Inc. All rights reserved.
h qa h qa qa h qa
lO
TESTBANK - h
LilleysPharmacologyfor CanadianH
h
RePractice,4th Edition(Sealock),Ch
58|All Chapters
h h
,TABLEOFCONTENTS
,Chapter 01: Nursing Practice in CanadaandDrug Therapy
qa qa qa qa qa aq qa
Sealock: Lilley’s Pharmacologyfor Canadian Health Care Practice, 4th Edition
qa qa qa qa qa qa qa qa
MULTIPLE CHOICE qa
1. Which is aj udgement about aparticularpatient’spotential need or problem?
h qa qa h h qa qa qa hqa h
a. A goal h
b. An assessment h
c. Subjective data qa
d. A nursing diagnosis h h
ANSWER: D hq a
Nursing diagnosis isthe phase of the nursing process during which a clinical judgement is made about how
h hqa qa hqa qa h hqa h h h hqa qa hqa
onditions and life processesor vulnerability forthatresponse.
qa qa qa qa qa
DIF: Cognitive Level:Knowledge qa
2. The patient is to receiveoral furosemide (Lasix)e veryday; however, because the patient is unable to swallow
hqa qa qa qa qa qa hqa qa qa hqa qa qa qa
ation orally, asordered. The nurse needs to contact thephysician. What type of problem is this?
h qa qa qa qa qa h hqa qa hqa h h hqa qa
a. A “right time”problem h qa
b. A “right dose”problem h h
c. A “right route”problemh h
d. A “right medication”problem
h qa
ANSWER: C q a
This is a “right route” problem: the nurse cannot assume the routeand must clarify the route with the prescrib
qa h hq a h qa qa qa h qa qa qa h qa qa qa h
roblembecause the ordered frequency has not changed. This is not a “right dose”problembecause thedose is
h qa hqa qa qa h qa qa qa h qa h h qa qa
wallow.This is not a “right medication”problembecauset he medication ordered will not change, just ther
qa hqa h qa hqa qa h qa hqa h qa qa qa qa hqa qa
DIF: CognitiveLevel: Application qa h
3. The nurse has been monitoringthe patient’sprogresson his newdrug regimen sincethe first dosea nd has been hqa qa hqa qa h h qa qa h qa hqa
ible adverseeffects. What nursing process phase is the nursepractising?
qa qa qa qa h qa qa hqa
a. Planning
b. Evaluation
c. Implementation
d. Nursing diagnosis h
ANSWER: B q a
Monitoring thepatient’sprogress ispart of thee valuation phase. Planning, implementation, a nd nursing diagn
h qa qa qa qa h h qa h qa qa qa hqa h
xample.
DIF: CognitiveLevel: Application qa h
4. Thenurse is caring fora patient who hasbeen newlydiagnosed with type 1 diabetes mellitus. Which statemen
qa h hqa h qa hqa qa h h qa qa qa h
mecriterion for this patient?
qa hqa h
a. Thepatient willfollow instructions. qa h qa
b. Thepatient will notexperience complications. qa hq a qa
c. Thepatientadherestothe new insulin treatment regimen. qa qa qa qa qa h qa
d. Thepatientdemonstratessafe insulin self-administrationtechnique. qa qa h
ANSWER: D hq a
Having the patient demonstrate safe insulin self-
h qa h qa qa h
administration technique is a specific and measurable outcome criterion. Followinginstructions and avoidin
h qa qa h qa hqa qa qa qa h qa qa
iccriteria. Adherencetothe newi nsulin treatment regimen is not objective andwouldbedifficultto measure
qa qa qa qa qa qa h qa hqa h qa h qa qa qa qa qa
DIF: CognitiveLevel: Application qa h
, Copyright © 2021, Elsevier Inc. All rights reserved.
h qa h qa qa h qa
